Clinical Scorecard: Effects of Radiation Dose Distribution on Quality of Life in Pediatric Brain Tumor Survivors: Insights from the Pediatric Proton/Photon Consortium Registry (PPCR)

At a Glance

Key Highlights

• Radiotherapy dose to brain substructures correlates with neurocognitive, endocrine, and sensory toxicities affecting HRQoL.
• Proton beam therapy offers superior normal tissue sparing compared to photon RT, potentially reducing adverse effects.
• Patient-reported outcome measures (PedsQL) are essential for direct assessment of HRQoL in pediatric brain tumor survivors.

Guideline-Based Recommendations

Diagnosis

• Use standardized delineation of intracranial substructures per published guidelines for accurate RT planning.
• Collect comprehensive demographic, treatment, and imaging data to contextualize HRQoL outcomes.

Management

• Prefer proton beam therapy over photon RT to minimize radiation dose to normal brain tissues.
• Avoid partial RT courses and ensure complete treatment plans are retrievable for outcome analysis.

Monitoring & Follow-up

• Administer PedsQL Generic Core and Infant Scales at baseline, end of RT, and annually for longitudinal HRQoL assessment.
• Use both child self-report and parent-proxy reports depending on age to capture comprehensive HRQoL data.

Risks

• Higher radiation doses to critical brain structures increase risk of neurocognitive decline, brain necrosis, cerebrovascular events, ototoxicity, visual toxicity, and endocrine dysfunction.
• Inconsistent RT variable reporting impedes comprehensive HRQoL analysis.

Patient & Prescribing Data

Children under 22 years with primary brain tumors treated with proton beam therapy and at least two years follow-up

Clinically delivered proton therapy plans without advanced avoidance techniques reflect real-world dose distributions impacting HRQoL outcomes.

Clinical Best Practices

• Obtain informed consent and IRB approval for registry-based data collection.
• Use validated HRQoL instruments (PedsQL) appropriate for patient age and reporting capability.
• Perform rigorous dosimetric review and contour verification by specialists to ensure data quality.
• Incorporate socioeconomic status estimates to contextualize HRQoL findings.
• Analyze longitudinal HRQoL data with mixed models accounting for individual variability.

References

• Pediatric Proton/Photon Consortium Registry (PPCR) Protocol
• PedsQL Measurement Model
• MIM Software Inc.